Tumor Tissue Samples for Advanced Ovarian Cancer

Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Recruiting Observational Study
Stage IIIA Ovarian Cancer Stage IIIB Ovarian Cancer Stage IIIC Ovarian Cancer Stage IV Ovarian Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Female
Study type
Observational
Participants needed
174 (estimated)
Sponsor
Gynecologic Oncology Group · Research network
Who this trial is looking for

This trial is looking for patients who have had surgery for advanced stage III or IV ovarian epithelial cancer. Participants will provide tumor tissue samples to help researchers understand how certain immune cells can predict treatment responses.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with stage III or IV ovarian epithelial cancer
  • I am enrolled in GOG-0136 or a GOG front-line platinum/taxol chemotherapy trial
  • I have fixed and paraffin-embedded tissue from my primary surgery
  • My tumor data includes major prognostic factors and follow-up information
  • I have measurable or nonmeasurable disease

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This research study is looking at tumor tissue samples from patients who have undergone surgery for advanced stage III or stage IV ovarian epithelial cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn how tumor infiltrating T cells can predict how patients will respond to treatment.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of stage III or IV ovarian epithelial cancer and enrolled on Gynecologic Oncology Group (GOG)-0136 and a GOG front-line platinum/taxol chemotherapy trial (GOG-0114, GOG-132, GOG-0158, or GOG-0162) * Must have fixed and paraffin-embedded tissue from primary surgery av…
Contacts

No contact information available.